Published in
Taylor and Francis Group, OncoImmunology, 1(8), 2018
DOI: 10.1080/2162402x.2018.1512455
Links
Tools
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Journal article published in 2018 by
Yaya Chu,
Sanghoon Lee,
Tishi Shah,
Changhong Yin,
Matthew Barth,
Rodney R. Miles,
Janet Ayello,
Erin Morris,
Lauren Harrison,
Carmella Van de Ven 
,
Paul Galardy ,
Stanton C. Goldman,
Megan S. Lim ,
Michelle Hermiston,
Linda M. McAllister-Lucas
and other authors.
,
Paul Galardy ,
Stanton C. Goldman,
Megan S. Lim ,
Michelle Hermiston,
Linda M. McAllister-Lucas
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 